ReviewCancers2024
PARP Inhibitors: Strategic Use and Optimal Management in Ovarian Cancer.
Nicholas Hirschl et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this paperpooled itcites it
ReviewCancers2024
Nicholas Hirschl et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.